- Home
- ACVA vs FTRE Comparison
ACVA vs FTRE Comparison
Compare ACVA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACVA | FTRE |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ACVA | FTRE |
|---|---|---|
| Price | $6.62 | $15.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $11.32 | ★ $14.06 |
| AVG Volume (30 Days) | ★ 3.7M | 1.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.75 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $759,606,000.00 | ★ $2,723,400,000.00 |
| Revenue This Year | $14.01 | N/A |
| Revenue Next Year | $12.62 | $3.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.22 | 1.00 |
| 52 Week Low | $4.07 | $3.97 |
| 52 Week High | $17.16 | $18.67 |
Technical Indicators
Market Signals| Indicator | ACVA | FTRE |
|---|---|---|
| Relative Strength Index (RSI) | 68.81 | 69.44 |
| Support Level | $6.18 | $9.01 |
| Resistance Level | $8.37 | $16.20 |
| Average True Range (ATR) | 0.37 | 0.72 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 87.08 | 87.01 |
Price Performance
Historical ComparisonAbout ACVA ACV Auctions Inc.
ACV Auctions Inc operates a mobile platform for wholesale car auctions. It provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers. Additionally, the company's marketplace platform is supported by remarketing centers in various locations throughout the United States.
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.